首页 › 基金 › BAKER BROS. ADVISORS LP › IRON

BAKER BROS. ADVISORS LP 对 IRON 的持仓历史

DISC MEDICINE INC · 医疗保健

BAKER BROS. ADVISORS LP 在 Q3 2026 的 13F 申报中披露持有 IRON(DISC MEDICINE INC)349,657 股,市值约 US$22.9M,约占其申报组合的 0.11%,在其申报持仓中市值排名第 44 位。 BAKER BROS. ADVISORS LP 最近 8 个申报季度中有 8 个季度披露了 IRON 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)349.66K 股
申报持仓市值$22.89M
组合权重0.11%
首次申报Q4 2024
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

BAKER BROS. ADVISORS LP 对 IRON 的持仓演变

BAKER BROS. ADVISORS LP 于 Q4 2024 首次披露 IRON 持仓:77,050 股(约 US$4.9M)。 该持仓在 Q4 2025 达到峰值 337,050 股,市值约 US$26.8M。 在 8 次申报中,BAKER BROS. ADVISORS LP 2 次增持、0 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 349,657 股、市值约 US$22.9M。 持仓曾出现大幅变动:Q2 2025 增持约 337% (随后一个季度股价上涨 25%)。

逐季持仓明细

季度股数金额变化
Q4 2024 77.05K $4.88M 新进
Q1 2025 77.05K $3.82M 持有
Q2 2025 337.05K $17.85M 增持
Q3 2025 337.05K $22.27M 持有
Q4 2025 337.05K $26.77M 持有
Q1 2026 349.66K $22.36M 增持
Q2 2026 349.66K $25.57M 持有
Q3 2026 349.66K $22.89M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IRON 与 13F 数据

IRON(DISC MEDICINE INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 IRON,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$107.0M), Atlas Venture Life Science Advisors, LLC (US$90.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IRON 的基金

查看 IRON 的全部基金持有人 →

常见问题

How long has BAKER BROS. ADVISORS LP held IRON?

BAKER BROS. ADVISORS LP has disclosed IRON holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is BAKER BROS. ADVISORS LP's current position in IRON?

As of Q3 2026, BAKER BROS. ADVISORS LP holds 349.66K shares of IRON (DISC MEDICINE INC), valued at $22.89M, representing 0.11% of its reported portfolio and ranking #44.

Has BAKER BROS. ADVISORS LP been buying or selling IRON?

In the latest 13F filing (Q3 2026), BAKER BROS. ADVISORS LP held unchanged its position in IRON. The position peaked in Q4 2025 at 337.05K shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.